Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily …

WV Kern, O Marchetti, L Drgona, H Akan… - Journal of clinical …, 2013 - ascopubs.org
Purpose This double-blind, multicenter trial compared the efficacy and safety of a single
daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic …
被引用次数：110 相关文章

[引用][C] Oral antibiotics for fever in low-risk neutropenic patients with cancer: A double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice …

WV Kern, O Marchetti, L Drgona, H Akan… - Journal of clinical …, 2013 - difusion.ulb.ac.be
[PDF] hacettepe.edu.tr

[PDF][PDF] Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin …

W Kern, O Marchetti, L Drgona… - JOURNAL OF …, 2013 - avesis.hacettepe.edu.tr
Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind,
Randomized, Multicenter Trial Comparing Page 1 Oral Antibiotics for Fever in Low-Risk …

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily …

WV Kern, O Marchetti, L Drgona, H Akan, M Aoun… - 2013 - cabidigitallibrary.org
Purpose: This double-blind, multicenter trial compared the efficacy and safety of a single
daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic …

[引用][C] Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin …

WV KERN, O MARCHETTI, L DRGONA… - Journal of clinical …, 2013 - pascal-francis.inist.fr
Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind,
Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily …

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily …

WV Kern, O Marchetti, L Drgona, H Akan… - Journal of Clinical …, 2013 - europepmc.org
Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind,
randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin …

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With …

WV Kern, O Marchetti, L Drgona, H Akan… - Journal of Clinical …, 2013 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This double-blind, multicenter trial
compared the efficacy and safety of a single daily oral dose of moxifloxacin with oral …

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily …

WV Kern, O Marchetti, L Drgona, H Akan, M Aoun… - 2013 - pubmed.ncbi.nlm.nih.gov
Purpose This double-blind, multicenter trial compared the efficacy and safety of a single
daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic …

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With …

WV Kern, O Marchetti, L Drgona, H Akan, M Aoun… - Journal of Clinical … - folia.unifr.ch
English Purpose This double-blind, multicenter trial compared the efficacy and safety of a
single daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile …

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With …

WV Kern, O Marchetti, L Drgona, H Akan, M Aoun… - Journal of Clinical … - sonar.ch
English Purpose This double-blind, multicenter trial compared the efficacy and safety of a
single daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile …